Back to search results

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Abroad (travel likely)RecruitingPHASE2

Conditions

Tuberculous Meningitis · HIV I Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Laboratory of clinical research on STD/AIDS - IPEC/FIOCRUZ, Rio de Janeiro, Brazil

    Contact: Study coordinator (Sandra WAGNER) · dra.wagner@gmail.com · + 55 21 38 65 96 23
    Contact: Principal Investigator (Beatriz GRINSZTEJN)

  • Instituto Nacional de Saude, Maputo, Mozambique

    Contact: Study coordinator (Marcia CHILUVANE) · marcia.chiluvane@ins.gov.mz
    Contact: Principal Investigator (Celso KHOSA)

  • Adult Infectious Diseases Centre, University Teaching Hospital, Lusaka, Zambia

    Contact: Study coordinator (Christabel Phiri) · chigweyassin@gmail.com
    Contact: Study coordinator (Seke Muzazu) · sekemuzazu@gmail.com
    Contact: Principal Investigator (Ducan CHANDA)
Study leads

  • Nathalie DE CASTRO, MD

    Principal Investigator

    AP-HP, Hôpital Saint-Louis

  • Celso KHOSA, MD

    Principal Investigator

    Instituto Nacional de Saúde, Mozambique

View source on ClinicalTrials.gov(opens in a new tab)